- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Jason Harris: Improving Patient Understanding and Promoting High-Value Care
Jason Harris, associate director of policy and programs at National Health Council, talks about promoting high-value, patient-centric care that reduces costs.
Jason Harris, associate director of policy and programs at National Health Council, talks about promoting high-value, patient-centric care that reduces costs.
Transcript
How can patient navigators be better used to improve patient care, patient understanding, and decision making?
They got to use it more. Obviously, there’s a different climate right now but overall that position and being that central source to help folks navigate the situation, for lack of a better term, is something that is really necessary and it’s one thing at the National Health Council we have some of the leading patient health advocacy organizations in the country and many of those groups do the same thing in terms of navigating their constituents to certain areas. Overall, that holistic environment we need to bring people together to be giving that push rather than having them to pull it out.
How is the National Health Council working to promote high-value care, while reducing costs?
We are doing a number of things. We have a value initiative we have launched in the last 2 years or so and much of that is a round of trying to understand how patients define value so we can go and start to implement things that can and can’t tie back to that. As well, we have a rubric and a get ready checklist for patient organizations to help them understand how they can become engaged in the value conversation whether that be with a value assessment body or in value-based payment, talking about how they can get involved in different programs and how they can use their advocacy to the best means possible.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More
